PBO panbio limited

Market Mad chart Pan Bio 20/5/2002

  1. 4,330 Posts.
    Subject UserName PostTime
    Market Mad PBO 20/5/if below1.20 target 1.04 ilrobbinrosso 21/5/02 5:09:21 AM
    Release from Escrow/Sale of Shares12/3/02 rainbow8 2/4/02 7:59:16 AM
    PBO: (exponential growth & revenues) rainbow8 2/4/02 7:55:15 AM
    Floats today. Bon1kers 9/4/01 9:31:51 AM
    RE: Att--Stange 69---floats on Monday. Bon1kers 7/4/01 7:50:39 AM
    Att--Stange 69---floats on Monday. Bon1kers 7/4/01 7:36:23 AM
    RE: “Top 100 Fastest Growing Private Companies”. boncers 27/3/01 5:44:16 PM
    RE: “Top 100 Fastest Growing Private Companies”. stangg69 22/3/01 11:49:19 AM
    “Top 100 Fastest Growing Private Companies”. boncers 22/3/01 12:33:34 AM




    ---------------------------------------------------------------------
    posted: Monday 9.00 p.m. Sydney time May 20, 2002
    ---------------------------------------------------------------------
    last price: $1.26 code: PBO
    ---------------------------------------------------------------------
    Panbio develops and sells diagnostic tests for Whooping Cough, Glandular Fever, Ross River Fever, and others. Since listing in 1998, the company has grown revenues exponentially. Last year, sales totalled $30 million, up from $10 million in 1998. Not bad for a company capped at just $62 million.
    It is true, the biotechnology sector is high risk these days, but that said, the Panbio story does stand up particularly well. In fact, relative to companies like Ambri and Cellestis, for example, Panbio looks to be a bargain from hereabouts.
    In terms of the chart and the technical evidence, the signal is bullish. The candles posted over the last 4 days are all pieces to a bullish puzzle. There is also the key 200-day moving average to consider, intersecting below the latest close at 1.23. Then there is the double bottom at 1.20. As I say, the technical evidence is bullish, and it does suggest 1.46 as the target.
    Panbio will probably trade higher from here, but having said that, there are no guarantees.
    ---------------------------------------------------------------------
    The evidence is pointing at a bullish outcome, but if below 1.20, the target will be 1.04.
    ---------------------------------------------------------------------
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.